Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Artificial Intelligence capable of distinguishing 96% of clinical cases of COVID-19

The technology is a digital health care tool, capable of differentiating more than 20 thousand diseases with an accuracy of more than 90%, and was recently tested with confirmed cases of COVID-19 to measure its effectiveness. In addition, this technology can be accessed for free through its web platform.

Symptoma is a development based on Artificial Intelligence (AI), to assist in the diagnosis of diseases. Recently, an article was published in the journal Nature, in which the developers explain that it is currently able to distinguish COVID-19 with an accuracy of 96.32% and even 100% when only the symptoms related to this disease and risk factors are considered.

The article entitled "An artificial intelligence-based first-line defence against COVID-19: digitally screening citizens for risks via a chatbot". In the article they propose, the Digital Health services, for the pre-diagnosis of possible people infected with the SARS-CoV-2 virus. This, through computer-based approaches and digital technologies, it is possible to create symptom verifiers that allow users to select the symptoms they have presented so far.

"Symptoma uses (free-text) keywords and symptoms, age and sex as input from a user. The prediction engine then references a proprietary symptom-disease database curated by medical doctors and built upon a large text corpus that includes scientific publications, medical textbooks, patient self-reports, and Electronic Health Records, to map this input to possible causes," the study mentions in the Methods section.

In addition, the predictions also collect several relevant factors, such as the frequency rate of symptom appearance, the incidence of specific diseases in the country and geographical area, in this way the AI classifies more than 20,000 causes and gives as a result of the analysis the 30 most probable ones.

Symptoma was tested against other diagnostic verifiers of ear, nose and throat diseases, exceeding them significantly in their results, besides related to the identification of COVID-19 cases. It was also tested with negative cases of COVID-19, for this test it was necessary to collect more than one thousand negatives, in addition they made restrictions to determine that they were not confused with other diseases with similar symptoms such as severe acute respiratory syndrome or avian influenza.

Symptoma provides a diagnostic accuracy with regards to COVID-19 higher than alternative approaches. It is usable in numerous languages and trends it exhibits correlates strongly with those found nationally. On the grounds, we believe that Symptoma is a highly valuable tool in the global COVID-19 crisis," they note as a conclusion.

The platform is freely accessible through the following link https://www.symptoma.com/ and reporting the symptoms is a very simple task, as the chatbot understands several languages and the questions are clear and easy to understand.

Outstanding news

News by country

Share

Digital Health in the world

  • — Science Brief: Omicron (B.1.1.529) Variant/CDC updates
    See more
  • —Coronavirus resource center/Johns Hopkins
    See more
  • — Epidemiological tracing of COVID-19 contacts / Johns Hopkins Course
    See more
  • — SARS-CoV-2 infection behavior / FCS calculator
    See more
  • — Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic/ Article The Lancet
    See more
  • —Genomic Epidemiology Tracker/GISAID
    See more
  • — Mexican Genomic Surveillance Consortium
    See more
Secured By miniOrange